Nephro Care India Limited
NSE: NEPHROCARE · Other · sector
₹79.80NSE close 2026-10-26
Key numbers
Market cap₹132 cr
Price₹79.80
52w high / low₹156 / ₹50
P/E24.2xSector median 14.4x
P/B3.3xSector median 1.7x
Book value₹24.5
Dividend yield–Sector median 0.37%
ROE13.9%Sector median 13.8%
ROCE19.9%Sector median 19.6%
OPM9.9%Sector median 10.4%
Debt / equity–Sector median 0.29x
EV/EBITDA8.3xSector median 8.4x
Interest cover35.4x
Current ratio2.02x
Sales growth 3y–Sector median +7.7%
Profit growth 3y–Sector median +16.6%
PEG–
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 688 companies in Other (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Operating profit covered interest 35.4x in the last 12 months.
- Operating cash flow was below net profit in 2 of the last 3 years (FY26, FY24).
- Other income was 34% of net profit in the last 12 months.
- No dividend in the last 3 financial years.
- Price ₹79.80 on 2026-10-26: -49.0% from the 52-week high, +59.4% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹257.00 · low ₹56.90
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Mar 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | 14 | 28 | 39 | 23 | 49 | 29 |
| EBITDA | 3 | 3 | 4 | 2 | 4 | 4 |
| OPM % | 19.2% | 10.0% | 11.2% | 8.5% | 8.0% | 12.4% |
| Other income | 0 | 1 | 1 | 0 | 1 | 0 |
| Net profit | 1 | 1 | 2 | 0 | 1 | 2 |
| EPS (₹) | 0.72 | 0.96 | 1.18 | 0.26 | 0.87 | 0.98 |
| Revenue YoY | +249.7% | +3.0% | ||||
| Profit YoY | +88.2% | +11.0% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|
| Revenue | 27 | 46 | 89 | 141 |
| EBITDA | 6 | 6 | 8 | 14 |
| Net profit | 4 | 4 | 3 | 5 |
| EPS (₹) | 3.80 | 2.38 | 2.04 | 3.29 |
| Revenue growth | +69.0% | +92.8% | – | |
| Profit growth | -17.5% | -7.4% | – | |
| Dividend / share (₹) | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | -38.6% (2y) | -39.9% |
Balance sheet
| ₹ cr | FY24 | FY25 | FY26 |
|---|---|---|---|
| Shareholders' equity | 3 | 37 | 40 |
| Cash & equivalents | 1 | 21 | 16 |
| Total assets | 21 | 68 | 73 |
| Fixed assets | – | 31 | 34 |
| Investments | 7 | 3 | 2 |
| Inventory | 0 | 1 | 2 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY24 | FY25 | FY26 |
|---|---|---|---|
| Cash from operations | 1 | 7 | 2 |
| Cash from investing | -8 | -40 | -0 |
| Cash from financing | 6 | 36 | 0 |
| Capex | 0 | 29 | 8 |
| Free cash flow | 1 | -22 | -5 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY24 | FY25 | FY26 |
|---|---|---|---|
| ROE % | 141.3% | 9.8% | 8.3% |
| ROCE % | 199.1% | 13.4% | 11.9% |
| Inventory days | 14 | 34 | 32 |
| Working capital days | -20 | 113 | 64 |
Peers in Other
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| TSFINV | ₹8,585 cr | 17.6x | 1.4x | 8.4% | 3.6% | 20.5% | +121.7% | 2.30% |
| KRISHANA | ₹6,339 cr | 39.9x | 11.3x | 41.6% | 23.2% | 12.6% | +95.7% | 0.05% |
| MARINE | ₹5,431 cr | 84.2x | 11.0x | 14.3% | 18.0% | 10.8% | +25.6% | 0.07% |
| ZOTA | ₹4,139 cr | – | 6.0x | -22.5% | -12.4% | -0.5% | +56.7% | 0.07% |
| AIMTRON | ₹3,319 cr | 71.7x | 17.1x | 28.0% | 31.8% | 21.8% | – | – |
| ACCORD | ₹2,984 cr | – | 261.7x | 12.4% | 12.0% | 2.4% | – | – |
| MONOLITH | ₹2,646 cr | 64.6x | 24.3x | 36.0% | 48.7% | 24.4% | – | – |
| UTSSAV | ₹2,390 cr | 40.2x | 14.1x | 43.4% | 54.7% | 7.9% | – | – |
| BETA | ₹2,200 cr | 40.6x | 5.0x | 16.4% | 17.0% | 20.8% | – | – |
| NEPHROCARE | ₹132 cr | 24.2x | 3.3x | 13.9% | 19.9% | 9.9% | – | – |
Business segments (FY26)
| Segment | Revenue | Share | EBIT | Margin |
|---|---|---|---|---|
| Income from IPD Services | ₹43 cr | 47.9% | ₹33 cr | 75.5% |
| Income from OPD Services | ₹25 cr | 27.9% | ₹21 cr | 84.1% |
| Income from sale of medicines from pharmacy | ₹20 cr | 22.5% | ₹5 cr | 22.7% |
| Add: Others | ₹1 cr | 0.9% | ₹2 cr | 193.2% |
| Add: Profit on Sale of Investment | ₹0 cr | 0.5% | ₹0 cr | 0.0% |
| Add: Dialysis machine Rental charges | ₹0 cr | 0.2% | ₹0 cr | 0.0% |
| Add: Interest Income | ₹0 cr | 0.1% | ₹0 cr | 0.0% |
| Add: Technician Charges for Dialysis | ₹0 cr | 0.0% | ₹0 cr | 0.0% |
| Less: Discount | ₹-0 cr | -0.1% | ₹0 cr | 0.0% |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | |
| Industry | Other |
| Sub-industry | |
| Symbol | NEPHROCARE |
| BSE code | – |
| ISIN | INE0SUN01013 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results); price = NSE close 2026-10-26.